Safety of AZD1222 COVID19 vaccine and low Incidence of SARSCoV2 infection in Botswana following ChAdOx1AZD1222 vaccination A singlearm openlabel interventional study final study results

Simple item page
dc.article.end-page43en
dc.article.start-page35en
dc.citation.doi10.1016/J.IJREGI.2023.11.002en
dc.contributor.authorJ Makhemaen
dc.contributor.authorE Shavaen
dc.contributor.authorAlane Izuen
dc.contributor.authorT Gaolatheen
dc.contributor.authorL Kuateen
dc.contributor.authorE et alen
dc.date.accessioned2024-09-19T14:21:15Z
dc.date.available2024-09-19T14:21:15Z
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationSCOPUSen
dc.identifier.issn27727076en
dc.identifier.urihttps://hdl.handle.net/10539/40986
dc.journal.titleSafety of AZD1222 COVID19 vaccine and low Incidence of SARSCoV2 infection in Botswana following ChAdOx1AZD1222 vaccination A singlearm openlabel interventional study final study resultsen
dc.journal.volume10en
dc.titleSafety of AZD1222 COVID19 vaccine and low Incidence of SARSCoV2 infection in Botswana following ChAdOx1AZD1222 vaccination A singlearm openlabel interventional study final study resultsen
dc.typeJournal Articleen
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Journal Article.pdf
Size:
1.12 MB
Format:
Adobe Portable Document Format
Description:
Bitstream uploaded by REST Client
Download
Collections
Academic Wits Research Outputs (All submissions)